Andrew P. Beelen

Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i> Mutant Pancreatic Cancer

Craig M. Goodwin, Andrew M. Waters, Jennifer E. Klomp et al. · Cancer Research · 2022 · 144 citations · Full text

Effects of Food on the Relative Bioavailability of Lapatinib in Cancer Patients

Kevin M. Koch, Nandi J. Reddy, Roger B. Cohen et al. · Journal of Clinical Oncology · 2009 · 138 citations · Full text

Increased Recognition of Powassan Encephalitis in the United States, 1999–2005

Steven R. Hinten, Geoffrey A. Beckett, Kathleen F. Gensheimer et al. · Vector-Borne and Zoonotic Diseases · 2008 · 133 citations

Powassan Encephalitis, Virus Epidemiology, Powv Disease +15

Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers

Ronnatrai Rueangweerayut, Germana Bancone, Emma J. Harrell et al. · American Journal of Tropical Medicine and Hygiene · 2017 · 117 citations · Full text

Modulation of Cell Cycle Progression in Human Tumors: A Pharmacokinetic and Tumor Molecular Pharmacodynamic Study of Cisplatin Plus the Chk1 Inhibitor UCN-01 (NSC 638850)

Raymond P. Perez, Lionel D. Lewis, Andrew P. Beelen et al. · Clinical Cancer Research · 2006 · 72 citations · Full text